Tag Archives: twiceyearly

European Medicines Agency gives the green light for twice-yearly HIV prevention drug

European Medicines Agency gives the green light for twice-yearly HIV prevention drug

LONDON (AP) — The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing HIV, which scientists say could help end the virus’ transmission. In a statement on Friday, the EU drug regulator said its evaluations of lenacapavir, sold as Yeytuo in Europe by Gilead Sciences, showed the drug is “highly effective” and “considered to be of …

Read More »

EU regulator backs Gilead's twice-yearly injection for HIV prevention – Reuters

EU regulator backs Gilead’s twice-yearly injection for HIV prevention  Reuters E.U. regulator approves injectable HIV drug that experts say could help stop transmission  NBC News EU regulators back twice-yearly HIV injection  Euronews.com Yeztugo approval: A new era in HIV prevention  Newsday Expert: Lenacapavir Shows 100% Efficacy in Key Trial, Offering Transformative Twice-Yearly HIV Prevention  Pharmacy Times Source link

Read More »

EU regulators back twice-yearly HIV injection – Euronews.com

EU regulators back twice-yearly HIV injection  Euronews.com EU regulator backs Gilead’s twice-yearly injection for HIV prevention  Reuters EU regulator approves injectable HIV drug that experts say could help stop transmission  PBS Yeztugo approval: A new era in HIV prevention  Newsday Does six-monthly PrEP have a future following the collapse of global HIV funding?  Aidsmap Source link

Read More »

WHO recommends Gilead's twice-yearly injection for HIV prevention – Reuters

WHO recommends Gilead’s twice-yearly injection for HIV prevention  Reuters WHO recommends twice-a-year HIV prevention shot as concern looms over funding for global HIV fight  CNN Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis  World Health Organization (WHO) Gilead to provide HIV prevention drug to 2 million people in lower-income countries at cost  STAT WHO urges rollout of first …

Read More »